These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 291484)

  • 21. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.
    Yagoda A
    Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous necrosis in osteosarcoma.
    Springfield DS; Schakel ME; Spanier SS
    Clin Orthop Relat Res; 1991 Feb; (263):233-7. PubMed ID: 1993380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.
    Karakousis CP; Holtermann OA; Holyoke ED
    Cancer Treat Rep; 1979; 63(11-12):2071-5. PubMed ID: 393389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy using cisplatin in bone and soft tissue sarcoma].
    Isu K; Goto M; Yamawaki S; Ubayama Y
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):100-4. PubMed ID: 3467652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of high-dose methotrexate in patients with unresectable metastatic osteosarcoma.
    Edmonson JH; Creagan ET; Gilchrist GS
    Cancer Treat Rep; 1981; 65(5-6):538-9. PubMed ID: 6972255
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.
    Lacave AJ; Izarzugaza I; Antón Aparicio LM; Valle Pereda M; Gracia Marco JM; Buesa JM
    Am J Clin Oncol; 1983 Feb; 6(1):35-8. PubMed ID: 6682284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro thermochemotherapy of human osteosarcoma cells with cis-dichlorodiammineplatinum (II).
    Yamane T; Nakabayashi H; Ito S; Sumii H; Kawai A
    Hiroshima J Med Sci; 1986 Sep; 35(3):191-5. PubMed ID: 3468096
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
    Merrin CE
    Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II).
    Mills RC; Maurer LH; Forcier RJ; Grace WR; Burke GP; Karp DD; Smith RC; Mcintyre OR; Bean C
    Cancer Treat Rep; 1977; 61(3):477-9. PubMed ID: 872146
    [No Abstract]   [Full Text] [Related]  

  • 33. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.
    Basaran M; Bavbek ES; Saglam S; Eralp L; Sakar B; Atalar AC; Bilgic B; Ozger H; Onat H
    Oncology; 2007; 72(3-4):255-60. PubMed ID: 18185020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
    Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
    Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auditory function in pediatric osteosarcoma patients treated with multiple doses of cis-diamminedichloroplatinum(II).
    Ruiz L; Gilden J; Jaffe N; Robertson R; Wang YM
    Cancer Res; 1989 Feb; 49(3):742-4. PubMed ID: 2910492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study.
    Nitschke R; Fagundo R; Berry DH; Falletta JM
    Cancer Treat Rep; 1979 Mar; 63(3):497-9. PubMed ID: 427829
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced bladder cancer: therapy with cis-dichlorodiammineplatinum(II), adriamycin, and 5-fluorouracil.
    Williams SD; Donohue JP; Einhorn LH
    Cancer Treat Rep; 1979; 63(9-10):1573-6. PubMed ID: 498156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
    Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
    Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
    Von Hoff DD; Schilsky R; Reichert CM; Reddick RL; Rozencweig M; Young RC; Muggia FM
    Cancer Treat Rep; 1979; 63(9-10):1527-31. PubMed ID: 387223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.